Business Context and Reporting Period
This Form 8-K was filed by Inpixon (trading symbol: INPX) on April 27, 2022. The report details the entry into a Material Definitive Agreement involving a significant investment in a senior convertible debenture issued by an unaffiliated insurance technology company (the "Seller").
Key Financial Metrics and Transaction Details
- Investment Amount: Inpixon purchased a debenture with an aggregate principal amount of $6,050,000 for a purchase price of $5,500,000 (reflecting a 10% Original Issue Discount).
- Interest Rate: 12% per annum, with 12 months of interest guaranteed.
- Maturity: 12 months from the original issue date (April 27, 2023), with an option for the Seller to extend by 3 months.
- Conversion Terms:
- Voluntary Conversion: Available after 270 days at $5.00 per share (reducing to $4.00 if no mandatory conversion occurs within 360 days or upon default).
- Mandatory Conversion: Triggered by a Qualified Offering (public offering of at least $5,000,000 or SPAC merger) at 75% of the issuance price.
- Prepayment Penalties: 20% premium if prepaid before maturity; 30% premium if prepaid during the extension period.
- Default Consequences: Immediate payment of 130% of the outstanding amount and an interest rate increase to the lesser of 18% or the maximum legal rate.
Material Changes Versus Prior Period
The filing does not provide comparative financial data for Inpixon's own operations (revenue, profit, or cash flow) as this is a current report regarding a specific transaction rather than a periodic financial statement. The material change is the acquisition of a new financial asset (the Debenture) and the associated cash outflow of $5,500,000.
Outlook, Risks, and Contingencies
- Guarantees: The transaction is secured by a guarantee from all direct subsidiaries of the Seller.
- Default Risks: Defined events of default include failure to pay, bankruptcy, breach of covenants, or monetary judgments against the Seller exceeding $250,000.
- Liquidity Impact: The filing does not explicitly state the impact on Inpixon's overall liquidity or cash reserves, only the specific purchase price paid.
- Future Filings: Full text of the agreements will be filed as exhibits to the Form 10-Q for the quarter ended June 30, 2022.
Key Facts for Investor Verification
- Verify the identity and financial health of the "Seller" (the insurance technology company) to assess the risk of the $6.05 million exposure.
- Confirm the impact of the $5.5 million cash outflow on Inpixon's current cash position and liquidity.
- Monitor the Seller's progress toward a "Qualified Offering" or SPAC merger, which would trigger mandatory conversion of the debt.
- Review the upcoming Form 10-Q for the full text of the Securities Purchase Agreement and Subsidiary Guarantee.